253 related articles for article (PubMed ID: 30516132)
1. Treatment of canine sarcoptic mange with afoxolaner (NexGard
Hampel V; Knaus M; Schäfer J; Beugnet F; Rehbein S
Parasite; 2018; 25():63. PubMed ID: 30516132
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a chewable tablet containing sarolaner, moxidectin, and pyrantel (Simparica Trio
Becskei C; Liebenberg J; Fernandes T; Borowski S; D'Hanis L; Mahabir SP
Parasit Vectors; 2023 Nov; 16(1):441. PubMed ID: 38012719
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of afoxolaner plus milbemycin oxime and afoxolaner alone as treatment for sarcoptic mange in naturally infested dogs.
Romero-Núñez C; Bautista-Gómez LG; Sheinberg G; Martín-Cordero A; Flores-Ortega A; Heredia-Cárdenas R
Can J Vet Res; 2020 Jul; 84(3):212-216. PubMed ID: 32801456
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of afoxolaner plus milbemycin oxime chewable tablets (NexGard Spectra
Tielemans E; Lebon W; Dumont P; Taweethavonsawat P; Larsen D; Rehbein S
Vet Parasitol; 2017 Apr; 238():87-89. PubMed ID: 28408213
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of afoxolaner in a clinical field study in dogs naturally infested with Sarcoptes scabiei.
Beugnet F; de Vos C; Liebenberg J; Halos L; Larsen D; Fourie J
Parasite; 2016; 23():26. PubMed ID: 27317462
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of two formulations of afoxolaner (NexGard® and NexGard Spectra®) for the treatment of generalised demodicosis in dogs, in veterinary dermatology referral centers in Europe.
Lebon W; Beccati M; Bourdeau P; Brement T; Bruet V; Cekiera A; Crosaz O; Darmon C; Guillot J; Mosca M; Pin D; Popiel J; Pomorska Handwerker D; Larsen D; Tielemans E; Beugnet F; Halos L
Parasit Vectors; 2018 Sep; 11(1):506. PubMed ID: 30201031
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of milbemycin oxime/afoxolaner chewable tablets (NEXGARD SPECTRA
Di Cesare A; Morelli S; Morganti G; Simonato G; Veronesi F; Colombo M; Berlanda M; Lebon W; Gallo M; Beugnet F; Traversa D
Parasit Vectors; 2021 Mar; 14(1):143. PubMed ID: 33676579
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of orally and topically administered fluralaner (Bravecto
Chiummo R; Petersen I; Plehn C; Zschiesche E; Roepke R; Thomas E
Parasit Vectors; 2020 Oct; 13(1):524. PubMed ID: 33069261
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of oral afoxolaner plus milbemycin oxime chewables against induced infestations with Dermacentor reticulatus in dogs.
Rehbein S; Fourie JJ; de Vos C; Anderson A; Larsen DL; Jeannin P
Parasitol Res; 2016 May; 115(5):1845-51. PubMed ID: 26815036
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of combination products containing sarolaner, moxidectin and pyrantel (Simparica Trio™) or afoxolaner and milbemycin (NexGard Spectra
Packianathan R; Hodge A; Bruellke N; Jackson C; Maeder S
Parasit Vectors; 2020 Sep; 13(1):448. PubMed ID: 32891172
[TBL] [Abstract][Full Text] [Related]
11. Efficacy against nematode infections and safety of afoxolaner plus milbemycin oxime chewable tablets in domestic dogs under field conditions in Europe.
Rehbein S; Knaus M; Mallouk Y; Breiltgens T; Brianti E; Capári B; Dantas-Torres F; Gau M; Joachim A; Kaulfuß KH; Kirkova Z; Lechner J; Mihalca AD; Mirabito R; Petkevičius S; Rapti D; Shukullari E; Sedeilhan M; Dollhofer D; Kley K; Lebon W; Visser M; Jeannin P
Parasitol Res; 2017 Jan; 116(1):259-269. PubMed ID: 27771803
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of fluralaner administered either orally or topically for the treatment of naturally acquired Sarcoptes scabiei var. canis infestation in dogs.
Taenzler J; Liebenberg J; Roepke RK; Frénais R; Heckeroth AR
Parasit Vectors; 2016 Jul; 9(1):392. PubMed ID: 27387742
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of oral afoxolaner for the treatment of canine generalised demodicosis.
Beugnet F; Halos L; Larsen D; de Vos C
Parasite; 2016; 23():14. PubMed ID: 27012161
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of oral afoxolaner plus milbemycin oxime chewables against induced gastrointestinal nematode infections in dogs.
Fankhauser R; Hamel D; Dorr P; Reinemeyer CR; Crafford D; Bowman DD; Ulrich M; Yoon S; Larsen DL
Vet Parasitol; 2016 Jul; 225():117-22. PubMed ID: 27369586
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the efficacy of monthly oral administration of afoxolaner plus milbemycin oxime (NexGard Spectra(®), Merial) in the prevention of adult Spirocerca lupi establishment in experimentally infected dogs.
Beugnet F; Crafford D; de Vos C; Kok D; Larsen D; Fourie J
Vet Parasitol; 2016 Aug; 226():150-61. PubMed ID: 27514901
[TBL] [Abstract][Full Text] [Related]
16. The intravenous and oral pharmacokinetics of afoxolaner and milbemycin oxime when used as a combination chewable parasiticide for dogs.
Letendre L; Harriman J; Drag M; Mullins A; Malinski T; Rehbein S
J Vet Pharmacol Ther; 2017 Jan; 40(1):35-43. PubMed ID: 27604405
[TBL] [Abstract][Full Text] [Related]
17. Monthly administrations of milbemycin oxime plus afoxolaner chewable tablets to prevent Angiostrongylus vasorum infection in dogs.
Lebon W; Tielemans E; Rehbein S; Dumont P; Yoon S; Beugnet F; Jeannin P; Larsen D; Halos L
Parasit Vectors; 2016 Sep; 9(1):485. PubMed ID: 27589951
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of afoxolaner or the combination of afoxolaner with milbemycin oxime against Otodectes cynotis in naturally infested dogs.
Sioutas G; Papadopoulos E; Madder M; Beugnet F; Tielemans E
Vet Parasitol; 2024 Feb; 326():110108. PubMed ID: 38154391
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of afoxolaner plus milbemycin oxime chewable tablets against naturally acquired intestinal nematodes in dogs.
Rehbein S; Dorr P; Bowman DD; Crafford D; Kusi I; Postoli R; Yoon S; Chester ST; Dollhofer D; Visser M; Larsen DL
Vet Parasitol; 2016 Feb; 217():29-35. PubMed ID: 26827857
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of a novel oral isoxazoline, sarolaner (Simparica™), for the treatment of sarcoptic mange in dogs.
Becskei C; De Bock F; Illambas J; Cherni JA; Fourie JJ; Lane M; Mahabir SP; Six RH
Vet Parasitol; 2016 May; 222():56-61. PubMed ID: 26928658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
